CCRT at St. Vincent’s

Cancer Research has undergone a huge transformation,

indeed a revolution in recent years. The long investment in

basic laboratory research is now beginning to pay off in a big

way to the benefit of current cancer sufferers. Previously,

treatment related research was largely confined to the use of

chemotherapy, surgery and radiotherapy to treat cancer,

which have saved many lives. We have now progressed and have entered the

exciting new era of 'translational research'.'Translational research' refers to the convergence of basic laboratory

research and clinical (i.e. patient orientated treatment research). Already new highly specific drugs, which lack the

side affects of cruder treatments such as chemotherapy have revolutionized the treatment of certain types of

leukaemia, breast cancer, lymphoma and colon cancer. Survival rates for patients with some of the most aggressive

forms of these diseases are already beginning to improve very substantially. Our Research activities have paralleled

these changes. Whereas we previously had a very substantial focus on trials which are aimed at maximising the

impact of chemotherapy, virtually our entire portfolio of research now consists of novel, highly specific treatments,

which hold a great promise for improved outcomes, with decreased side affects. It is increasingly recognised that this

effort must continue to unite Clinical and Laboratory Research, and the great majority of our Trials now have very

substantial Laboratory components. The rapidly expanding Team of Research Scientists at St. Vincent's Hospital

Campus, Dublin City University, University College Dublin, are working to try and improve and refine these treatments

for benefit of our patients. Read More ................

“The money raised by the Fighting

Cancer Triathlon virtually exclusively

used to support this Laboratory effort.”

Site Map | Privacy Statement

The Fighting Cancer Triathlon C/O Midland Triathlon Club